Matinas BioPharma Holdings, Inc.

About Matinas Biopharma

Matinas BioPharma Inc. is a development-stage biopharmaceutical company focused on the development of omega-3-based prescription therapeutics for the treatment of metabolic and cardiovascular conditions.

Learn about matinas biopharma

Drug Pipeline

MAT9001, Matinas BioPharma’s lead product candidate, is a next generation omega-3 prescription pharmaceutical product.

Learn about MAT9001

MAT8800 is Matinas BioPharma’s discovery program aiming to identify and optimize omega-3 compositions for the treatment of fatty liver diseases.

Learn about MAT8800
Investor Presentation

Investor Presentation

View our latest Corporate Presentation

View Presentation